Zimmer Biomet Holdings Shares Outstanding 2010-2024 | ZBH
Zimmer Biomet Holdings shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Zimmer Biomet Holdings shares outstanding for the quarter ending September 30, 2024 were 0.203B, a 3.33% decline year-over-year.
- Zimmer Biomet Holdings 2023 shares outstanding were 0.21B, a 0.29% decline from 2022.
- Zimmer Biomet Holdings 2022 shares outstanding were 0.21B, a 0.05% decline from 2021.
- Zimmer Biomet Holdings 2021 shares outstanding were 0.21B, a 1.64% increase from 2020.
| Zimmer Biomet Holdings Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 210 |
| 2022 | 210 |
| 2021 | 210 |
| 2020 | 207 |
| 2019 | 207 |
| 2018 | 204 |
| 2017 | 204 |
| 2016 | 202 |
| 2015 | 190 |
| 2014 | 172 |
| 2013 | 172 |
| 2012 | 176 |
| 2011 | 189 |
| 2010 | 201 |
| 2009 | 216 |
| Zimmer Biomet Holdings Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 203 |
| 2024-06-30 | 206 |
| 2024-03-31 | 206 |
| 2023-12-31 | 210 |
| 2023-09-30 | 210 |
| 2023-06-30 | 210 |
| 2023-03-31 | 210 |
| 2022-12-31 | 210 |
| 2022-09-30 | 210 |
| 2022-06-30 | 210 |
| 2022-03-31 | 210 |
| 2021-12-31 | 210 |
| 2021-09-30 | 211 |
| 2021-06-30 | 211 |
| 2021-03-31 | 210 |
| 2020-12-31 | 207 |
| 2020-09-30 | 209 |
| 2020-06-30 | 207 |
| 2020-03-31 | 207 |
| 2019-12-31 | 207 |
| 2019-09-30 | 207 |
| 2019-06-30 | 206 |
| 2019-03-31 | 206 |
| 2018-12-31 | 204 |
| 2018-09-30 | 205 |
| 2018-06-30 | 205 |
| 2018-03-31 | 205 |
| 2017-12-31 | 204 |
| 2017-09-30 | 204 |
| 2017-06-30 | 204 |
| 2017-03-31 | 203 |
| 2016-12-31 | 202 |
| 2016-09-30 | 203 |
| 2016-06-30 | 199 |
| 2016-03-31 | 202 |
| 2015-12-31 | 190 |
| 2015-09-30 | 206 |
| 2015-06-30 | 173 |
| 2015-03-31 | 173 |
| 2014-12-31 | 172 |
| 2014-09-30 | 172 |
| 2014-06-30 | 171 |
| 2014-03-31 | 172 |
| 2013-12-31 | 172 |
| 2013-09-30 | 172 |
| 2013-06-30 | 171 |
| 2013-03-31 | 171 |
| 2012-12-31 | 176 |
| 2012-09-30 | 175 |
| 2012-06-30 | 176 |
| 2012-03-31 | 179 |
| 2011-12-31 | 189 |
| 2011-09-30 | 189 |
| 2011-06-30 | 193 |
| 2011-03-31 | 194 |
| 2010-12-31 | 201 |
| 2010-09-30 | 200 |
| 2010-06-30 | 203 |
| 2010-03-31 | 204 |
| 2009-12-31 | 216 |
| 2009-09-30 | 215 |
| 2009-06-30 | 216 |
| 2009-03-31 | 222 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.842B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.284B | 25.22 |
| Stryker (SYK) | United States | $148.861B | 33.55 |
| Boston Scientific (BSX) | United States | $147.840B | 42.50 |
| EssilorLuxottica (ESLOY) | France | $120.398B | 0.00 |
| Medtronic (MDT) | Ireland | $112.636B | 16.73 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.153B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.736B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $39.899B | 20.69 |
| ResMed (RMD) | United States | $36.307B | 29.83 |
| Terumo (TRUMY) | Japan | $28.860B | 40.76 |
| Koninklijke Philips (PHG) | Netherlands | $24.692B | 18.90 |
| Insulet (PODD) | United States | $19.563B | 77.90 |
| Baxter (BAX) | United States | $16.252B | 10.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.094B | 34.30 |
| BellRing Brands (BRBR) | United States | $9.817B | 39.50 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.632B | 15.41 |
| ICU Medical (ICUI) | United States | $4.089B | 38.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.823B | 19.01 |
| Haemonetics (HAE) | United States | $3.684B | 17.98 |
| Envista Holdings (NVST) | United States | $3.623B | 26.99 |
| Perrigo (PRGO) | Ireland | $3.281B | 9.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.992B | 19.25 |
| GN Store Nord (GNNDY) | Denmark | $2.797B | 17.94 |
| Neogen (NEOG) | United States | $2.592B | 29.88 |
| LeMaitre Vascular (LMAT) | United States | $2.203B | 53.55 |
| AtriCure (ATRC) | United States | $1.926B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.514B | 26.50 |
| InMode (INMD) | Israel | $1.434B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.368B | 9.78 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.343B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
| Owens & Minor (OMI) | United States | $1.145B | 8.95 |
| Curaleaf Holdings (CURLF) | Canada | $0.903B | 0.00 |
| Evolus (EOLS) | United States | $0.895B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.881B | 15.54 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.678B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.572B | 25.24 |
| Omeros (OMER) | United States | $0.538B | 0.00 |
| Surmodics (SRDX) | United States | $0.530B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.418B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.91 |
| Quanterix (QTRX) | United States | $0.386B | 0.00 |
| Valneva SE (VALN) | France | $0.376B | 0.00 |
| Cerus (CERS) | United States | $0.336B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Biote (BTMD) | United States | $0.307B | 6.73 |
| OraSure Technologies (OSUR) | United States | $0.290B | 19.45 |
| Canopy Growth (CGC) | Canada | $0.263B | 0.00 |
| Zynex (ZYXI) | United States | $0.261B | 54.53 |
| High Tide (HITI) | Canada | $0.244B | 100.33 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.71 |
| Aurora Cannabis (ACB) | Canada | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 110.50 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| MacroGenics (MGNX) | United States | $0.193B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.153B | 0.00 |
| Veru (VERU) | United States | $0.152B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.29 |
| Jin Medical (ZJYL) | China | $0.136B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 11.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| InterCure (INCR) | Israel | $0.078B | 0.00 |
| INLIF (INLF) | $0.074B | 0.00 | |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 36.33 |
| Apyx Medical (APYX) | United States | $0.057B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |